Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Granular Hydrogels as Modular Biomaterials: From Structural Design to Biological Responses

Vaziri A., Maia R., Zhang P., Agresti L., Sjollema J., Shahbazi MA.

Narrative Review, published in Adv Healthc Mater (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Adv Healthc Mater (2026)
Reported sample size
—
Source database
Europe PMC
PMID
41013958
PMCID
PMC12817117
DOI
10.1002/adhm.202502462
Citations
3

Abstract (original English)

Over the past decade, granular hydrogels have been widely utilized as a cell-free or cell-laden platform to deliver therapeutics (e.g., cells and drugs) for tissue repair, or as a bioink or supporting bed for bioprinting. Owing to their inherent microporosity and modularity, various granular hydrogels with functional applications for in vivo use have been fabricated to enhance cell infiltration, spreading and migration, harness immune response, and promote tissue regeneration. In this review, an updated overview of the current state-of-the-art is provided for granular hydrogel development, by highlighting the interplay between design parameters and structural characteristics, like porosity, microstructure, rheological behavior, injectability, and degradability, and their influence on biological responses in various biomedical engineering applications.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AnimalsHumansBiocompatible MaterialsHydrogelsTissue EngineeringPorosity

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.